| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | — |
| R&D Expense | $48.9M | -30.1% |
| SG&A Expense | $22.9M | -5.1% |
| Operating Income | -$64.6M | +31.3% |
| Pre-tax Income | -$61.2M | +34.3% |
| Income Tax | $33K | — |
| Net Income | -$61.2M | +34.2% |
| EPS (Basic) | -$13.38 | -596.9% |
| EPS (Diluted) | -$13.38 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | -62.1% |
| Accounts Receivable | $43K | -95.4% |
| Current Assets | $133.8M | +38.0% |
| Total Assets | $136.8M | +34.4% |
| Current Liabilities | $39.2M | +140.7% |
| Total Liabilities | $95.7M | +400.4% |
| Stockholders' Equity | $41.1M | -50.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.7M | +126.9% |
| Capital Expenditures | $255K | +150.0% |
| Investing Cash Flow | -$69.1M | -176.3% |
| Financing Cash Flow | $13.8M | +2150.5% |
| Free Cash Flow | $22.5M | +126.6% |
| -596.9% |